The Accuracy of Diagnoses As Reported in Families with Cancer: a Retrospective Study
Overview
Authors
Affiliations
Assessment of risk of developing hereditary cancer and subsequent clinical surveillance is largely based on family history. It is considered standard practice to confirm as many diagnoses as possible in cancer families. Our aim was (1) to assess inaccuracies in reporting of cancers by families, (2) to assess the need for confirmation of diagnosis, and (3) to estimate how many families would have been entered unnecessarily or excluded from screening. A retrospective study of 595 case notes was performed in two centres. Methods of confirmation included information from the cancer registries, death certificates, hospital notes, and histopathological records. Accuracy varied by site of cancer and by the closeness of the relationship to the affected person. Reported abdominal malignancies were inaccurate in 20%, whereas 5% of reported breast cancers were inaccurate. In two families the family history of cancer proved fictitious. Management was altered in 231213 (11%) families following cancer confirmation. The results of the study favour verification of cancer diagnoses particularly if decisions regarding surveillance or prophylactic surgery are based on the family history.
Joint ABS-UKCGG-CanGene-CanVar consensus regarding the use of CanRisk in clinical practice.
Tsoulaki O, Tischkowitz M, Antoniou A, Musgrave H, Rea G, Gandhi A Br J Cancer. 2024; 130(12):2027-2036.
PMID: 38834743 PMC: 11183136. DOI: 10.1038/s41416-024-02733-4.
Ho W, Hassan N, Yoon S, Yang X, Lim J, Ishak N Lancet Reg Health West Pac. 2024; 44:101017.
PMID: 38333895 PMC: 10851205. DOI: 10.1016/j.lanwpc.2024.101017.
Cancer Risks Associated With and Pathogenic Variants.
Li S, Silvestri V, Leslie G, Rebbeck T, Neuhausen S, Hopper J J Clin Oncol. 2022; 40(14):1529-1541.
PMID: 35077220 PMC: 9084432. DOI: 10.1200/JCO.21.02112.
EUS-based Pancreatic Cancer Surveillance in Carriers Without a Family History of Pancreatic Cancer.
Katona B, Long J, Ahmad N, Attalla S, Bradbury A, Carpenter E Cancer Prev Res (Phila). 2021; 14(11):1033-1040.
PMID: 34341011 PMC: 8563408. DOI: 10.1158/1940-6207.CAPR-21-0161.
Gender differences in self-reported family history of cancer: A review and secondary data analysis.
Sieverding M, Arbogast A, Zintel S, Von Wagner C Cancer Med. 2020; 9(20):7772-7780.
PMID: 32835456 PMC: 7571831. DOI: 10.1002/cam4.3405.